Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

B&L/Woehlk

This article was originally published in The Gray Sheet

Executive Summary

Bausch & Lomb's $26.2 mil. cash acquisition of German contact lens maker Woehlk Contact Lens GmbH from Carl Zeiss will "significantly expand" its distribution network in Germany and give it the "number two position" in the German market, B&L says. The deal, which is slated to close in mid-October, is expected have a neutral impact on earnings in 2000 and be "slightly accretive" in 2001. Separately, B&L expects to report Oct. 12 details of a restructuring to include job cuts and associated cost savings. The Rochester, N.Y. firm will "integrate management of all product lines within a streamlined organizational structure" to more fully realize operational synergies, according to a Sept. 28 release

Latest Headlines
See All
UsernamePublicRestriction

Register

MT013919

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel